Literature DB >> 403871

Amino acid and protein metabolism in diabetes mellitus.

P Felig, J Wahren, R Sherwin, G Palaiologos.   

Abstract

In normal man, the fasting state is characterized by release of alanine and glutamine from muscle and in situ muscle catabolism of branched chain amino acids (lecucine, isoleucine, and valine). The alanine released by muscle is utilized by the liver for gluconeogenesis. Muscle nitrogen repletion occurs during protein feeding primarily by means of selective hepatic escape and muscle uptake of branched chain amino acids in ingested protein. In the diabetic, amino acid catabolism is exaggerated in the fasting state as reflected by increased uptake of alanine by the liver for gluconeogenesis and accelerated branched chain amino acid catabolism in muscle. After protein feeding, uptake of branched chain amino acids by muscle is reduced and these amino acids accumulate in increased amounts in arterial blood. Protein feeding also exaggerates the hyperglycemia of diabetes by causing an increase in hepatic glucose production. Diabetes is thus characterized by accelerated protein catabolism during fasting as well as diminished nitrogen repletion and hyperglycemia after protein feeding. The hyperketonemia of diabetes may however, have a restraining influence on protein catabolism thereby reducing alanine availability for gluconeogenesis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 403871

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  25 in total

1.  Altered Plasma Amino Acids and Lipids Associated With Abnormal Glucose Metabolism and Insulin Resistance in Older Adults.

Authors:  Richard D Semba; Marta Gonzalez-Freire; Ruin Moaddel; Kai Sun; Elisa Fabbri; Pingbo Zhang; Olga D Carlson; Mohammed Khadeer; Chee W Chia; Norman Salem; Luigi Ferrucci
Journal:  J Clin Endocrinol Metab       Date:  2018-09-01       Impact factor: 5.958

2.  Factors Beyond Carbohydrate to Consider When Determining Meantime Insulin Doses: Protein, Fat, Timing, and Technology.

Authors:  Alison B Evert
Journal:  Diabetes Spectr       Date:  2020-05

3.  Alterations of proteasome activities in skeletal muscle tissue of diabetic rats.

Authors:  S Merforth; A Osmers; B Dahlmann
Journal:  Mol Biol Rep       Date:  1999-04       Impact factor: 2.316

4.  Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. Role of substrate availability on estimates of whole body protein synthesis.

Authors:  P Castellino; L Luzi; D C Simonson; M Haymond; R A DeFronzo
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

Review 5.  Protein and diabetes: much advice, little research.

Authors:  Marion J Franz
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

6.  Combined pancreas and kidney transplantation normalizes protein metabolism in insulin-dependent diabetic-uremic patients.

Authors:  L Luzi; A Battezzati; G Perseghin; E Bianchi; I Terruzzi; D Spotti; S Vergani; A Secchi; E La Rocca; G Ferrari
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

7.  Control of cell protein catabolism in rat liver. Effects of starvation and administration of cycloheximide.

Authors:  F M Baccino; L Tessitore; G Cecchini; M Messina; M F Zuretti; G Bonelli; L Gabriel; J S Amenta
Journal:  Biochem J       Date:  1982-08-15       Impact factor: 3.857

8.  Insulin-mediated reduction of whole body protein breakdown. Dose-response effects on leucine metabolism in postabsorptive men.

Authors:  N K Fukagawa; K L Minaker; J W Rowe; M N Goodman; D E Matthews; D M Bier; V R Young
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

9.  Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients.

Authors:  K S Nair; G C Ford; K Ekberg; E Fernqvist-Forbes; J Wahren
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

Review 10.  Methods of assessing diabetic control.

Authors:  G D Molnar; G J Marien; A N Hunter; C H Harley
Journal:  Diabetologia       Date:  1979-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.